Home > Boards > US Listed > Biotechs > Sesen Bio (SESN)

what about the potential pps if a buyout occurs?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
voisybay123 Member Profile
 
Followed By 0
Posts 47
Boards Moderated 0
Alias Born 07/15/12
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/23/2021 5:26:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/23/2021 5:24:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/23/2021 5:23:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/23/2021 5:22:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/23/2021 5:19:14 PM
Sesen Bio amends capital raise to include additional $34.5M Seeking Alpha - 2/17/2021 12:10:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/17/2021 9:11:27 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/17/2021 9:08:50 AM
Sesen Bio nabs FDA priority review status for Vicineum marketing application Seeking Alpha - 2/16/2021 8:34:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/16/2021 7:10:12 AM
Sesen Bio Announces FDA Acceptance and Priority Review of its Biologics License Application for Vicineum™ Business Wire - 2/16/2021 7:00:00 AM
Dr. Thomas Cannell, President and CEO of Sesen Bio, to Host Conference Call to Provide a Business Update Business Wire - 2/12/2021 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/1/2021 8:03:42 AM
Sesen Bio Announces Successful Application Orientation Meeting (AOM) with the FDA for Vicineum™ Business Wire - 2/1/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/19/2021 8:01:12 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/13/2021 8:02:49 AM
Sesen Bio & Qilu Pharmaceutical Announce IND Application for Vicineum™ Accepted for Review by the National Medical Products... Business Wire - 1/13/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/11/2021 8:03:16 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/23/2020 11:48:09 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/21/2020 8:02:20 AM
Sesen Bio Submits Completed Biologics License Application to the FDA for Vicineum™ and Has Requested Priority Review Business Wire - 12/21/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/18/2020 8:04:42 AM
Sesen Bio Announces Positive Cost-Effectiveness Profile for Vicineum™ Based on the Final Evidence Report Issued by the Inst... Business Wire - 12/18/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/15/2020 8:00:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/9/2020 8:01:35 AM
voisybay123   Tuesday, 02/23/21 08:34:38 PM
Re: Dodgeball post# 6139
Post # of 6153 
what about the potential pps if a buyout occurs?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences